新华制药：关于2025年度利润分配方案的公告

Core Viewpoint - Xinhua Pharmaceutical announced a projected net profit of 290 million yuan for the fiscal year 2025, with a proposed cash dividend distribution plan for shareholders [1] Group 1: Financial Performance - The company expects to achieve a net profit attributable to shareholders of 290 million yuan for the year 2025 [1] - The proposed cash dividend is set at 1.5 yuan per 10 shares, which amounts to a total distribution of 105 million yuan [1] - The dividend distribution represents 36.05% of the projected net profit for 2025 [1] Group 2: Dividend Proposal - The total number of shares for the dividend calculation is based on a total share capital of 697 million shares [1] - The dividend proposal is subject to approval at the annual shareholders' meeting for the year 2025 [1]